0.831  0.021 (2.59%)		04-25 16:00
Open: 0.81 High: 0.849 Volume: 21,826		Pre. Close: 0.81 Low: 0.81 Market Cap: 60(M)

Short term
Mid term
Targets	6-month :	1.23	1-year :	1.42
Resists	First :	1.05	Second :	1.21
Pivot price	0.91
Supports	First :	0.79	Second :	0.66
MAs	MA(5) :	0.82	MA(20) :	0.93
	MA(100) :	1.06	MA(250) :	1.56
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	8.7	D(3) :	11
RSI	RSI(14): 35.3
52-week	High :	3.27	Low :	0.79

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ HYPR ] has closed above bottom band by 23.1%. Bollinger Bands are 48.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.85 - 0.85	0.85 - 0.86
Low:	0.8 - 0.8	0.8 - 0.81
Close:	0.82 - 0.83	0.83 - 0.84

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Thu, 25 Apr 2024
Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a Turnaround - Yahoo Canada Finance

Thu, 25 Apr 2024
Hyperfine (NASDAQ:HYPR) Shares Down 1.1% - MarketBeat

Tue, 23 Apr 2024
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System ... - Business Wire

Sat, 23 Mar 2024
SEC Baby Shelf Rules Stunt Hyperfine Inc.'s Fundraising Flexibility - TipRanks.com - TipRanks

Thu, 21 Mar 2024
Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Thu, 21 Mar 2024
Hyperfine, Inc. (HYPR) Q4 2023 Earnings Call Transcript - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	57 (M)
Shares Float	51 (M)
Held by Insiders	11.9 (%)
Held by Institutions	26.6 (%)
Shares Short	1,290 (K)
Shares Short P.Month	1,250 (K)

EPS	-0.63
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.16
Profit Margin	0 %
Operating Margin	-433 %
Return on Assets (ttm)	-26.4 %
Return on Equity (ttm)	-42.6 %
Qtrly Rev. Growth	88.5 %
Gross Profit (p.s.)	0
Sales Per Share	0.19
EBITDA (p.s.)	-0.83
Qtrly Earnings Growth	0 %
Operating Cash Flow	-42 (M)
Levered Free Cash Flow	-28 (M)

PE Ratio	-1.35
PEG Ratio	0
Price to Book value	0.71
Price to Sales	4.28
Price to Cash Flow	-1.14

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.